PETROSCRAP.COM » patent http://www.petroscrap.com Post, Search & Discuss on Buy / Sell Offers & Inquiries Fri, 10 Sep 2010 17:32:47 +0000 en hourly 1 http://wordpress.org/?v=3.0.1 mPhase Technologies Patent Portfolio Potential and Strategy Explained in Boston Investor Meetings http://www.petroscrap.com/mphase-technologies-patent-portfolio-potential-and-strategy-explained-in-boston-investor-meetings http://www.petroscrap.com/mphase-technologies-patent-portfolio-potential-and-strategy-explained-in-boston-investor-meetings#comments Sun, 27 Jun 2010 18:36:38 +0000 admin http://www.petroscrap.com/mphase-technologies-patent-portfolio-potential-and-strategy-explained-in-boston-investor-meetings Click Here to Read More]]> mPhase Technologies Patent Portfolio Potential and Strategy Explained in Boston Investor Meetings
LITTLE FALLS, NJ–(Marketwire – June 22, 2010) – mPhase Technologies, Inc. ( OTCBB : XDSL ) will hold a series of investor meetings in Boston tomorrow, June 23, during which CEO Ron Durando will explain the Company’s strategy for monetizing its new U.S. patent.

Read more on Marketwire

]]> http://www.petroscrap.com/mphase-technologies-patent-portfolio-potential-and-strategy-explained-in-boston-investor-meetings/feed 0 PURE Bioscience Granted Patent for Anhydrous SDC http://www.petroscrap.com/pure-bioscience-granted-patent-for-anhydrous-sdc http://www.petroscrap.com/pure-bioscience-granted-patent-for-anhydrous-sdc#comments Sat, 12 Jun 2010 14:35:39 +0000 admin http://www.petroscrap.com/pure-bioscience-granted-patent-for-anhydrous-sdc Click Here to Read More]]> PURE Bioscience Granted Patent for Anhydrous SDC
SAN DIEGO—-PURE Bioscience today announced that the United States Patent and Trademark Office issued patent number 7,732,486, which covers PURE’s anhydrous silver dihydrogen citrate technology.

Read more on Business Wire via Yahoo! Finance

]]> http://www.petroscrap.com/pure-bioscience-granted-patent-for-anhydrous-sdc/feed 0 Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States http://www.petroscrap.com/silence-therapeutics-issued-novel-rnai-patent-covering-high-value-cancer-target-in-united-states http://www.petroscrap.com/silence-therapeutics-issued-novel-rnai-patent-covering-high-value-cancer-target-in-united-states#comments Thu, 27 May 2010 08:35:15 +0000 admin http://www.petroscraps.com/silence-therapeutics-issued-novel-rnai-patent-covering-high-value-cancer-target-in-united-states Click Here to Read More]]> Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
Silence Therapeutics plc (AIM: SLN) (“Silence” or the “Company”) announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO). The issued patent, which deepens the Company’s diverse portfolio of RNA interference (RNAi …

Read more on SYS-CON Media

]]> http://www.petroscrap.com/silence-therapeutics-issued-novel-rnai-patent-covering-high-value-cancer-target-in-united-states/feed 0 EPO to grant patent notice to BioMimetic Therapeutics http://www.petroscrap.com/epo-to-grant-patent-notice-to-biomimetic-therapeutics http://www.petroscrap.com/epo-to-grant-patent-notice-to-biomimetic-therapeutics#comments Wed, 03 Feb 2010 16:56:17 +0000 admin http://www.petroscrap.com/epo-to-grant-patent-notice-to-biomimetic-therapeutics Click Here to Read More]]> Open house for Tri-Valley’s girls program Feb. 23
Seventh- and eighth-grade girls and their parents are invited to the seventh annual Reflections on Your Future event. The event is an introduction to a program designed to encourage girls to pursue interests in technology, science, math and engineering.

Read more on Contra Costa Times

ISA Technovation Awards 2010 announced
BANGALORE, INDIA: At a gala award night here, India Semiconductor Association, the semiconductor-driven industry body of the country, on Monday announced Technovation Awards for the year 2010.

Read more on CIOL

EPO to grant patent notice to BioMimetic Therapeutics
BioMimetic Therapeutics, Inc. announced today the European Patent Office (EPO) intends to grant patent application No. 05803356 titled “Platelet-Derived Growth Factor Compositions and Methods of Use Thereof”.

Read more on News-Medical-Net

]]> http://www.petroscrap.com/epo-to-grant-patent-notice-to-biomimetic-therapeutics/feed 0